Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 14

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Total article views   HTML views PDF downloads Totals
8,385 Dovepress* 7,043+ 962 8,005
PubMed Central* 1,342 463 1,805
Totals 8,385 1,425 9,810
*Since 18 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar